CES 2023 closed day one with a discussion panel on the new policy changes that will be implemented this year to help guide artificial intelligence (AI) innovations in a fair, accurate, and safe manner, including specific impacts on the healthcare industry at the Las Vegas Convention Center on Thursd
The police said they arrested the Chinese man in his 40s who refused to undergo quarantine and fled after testing positive for Covid-19 at the Incheon International Airport.According to the Incheon Central Police Station, the police arrested the Chinese national at a hotel in Seoul on Thursday for v
Despite poor investor sentiment in the bio-sector and concerns of a global recession, over 10 Korean biopharmaceutical companies are gearing up to undergo an initial public offering (IPO) process to list on the Korean stock market in 2023.Of the companies aiming to go public this year, if all goes a
The mRNA platform will continue to grab headlines for a while as it made history thanks to Moderna and Pfizer producing the world’s first and fastest Covid-19 vaccines using the mRNA platform. Of course, producing a vaccine in just 11 months is no small feat when compared to the usual 10-15 years re
The government is tightening quarantine on Chinese arrivals, but it should work out a more sustainable plan, an expert said Thursday.According to the Korea Disease Control and Prevention Agency (KDCA), the number of Chinese arrivals showed a positive test rate of 31.5 percent as of midnight Wednesda
Test methods based on liquid biopsy, one of the next-generation sequencing (NGS), is expanding its diagnostic field beyond cancer to include Alzheimer’s.The Korea Research Institute for Bioscience and Biotechnology (KRIBB) made these and other points in a Tuesday report, “The Status and Outlook of N
The government said Thursday that the positive rate for the Covid-19 polymerase chain reaction (PCR) test for travelers from China rose over 30 percent.According to the Korea Disease Control and Prevention Agency (KDCA), after conducting a PCR test on 327 short-term foreign residents among 1,924 peo
Amid the medical community’s escalating attacks on the Supreme Court’s permission for Oriental doctors to use ultrasonic diagnostic devices, an Oriental doctors’ group called for them to “stop disparaging and distorting the top court’s ruling.”The Association of Korean Medicine (AMK) said Wednesday
Samsung Bioepis has obtained a domestic product license for high-concentration Humira (adalimumab) biosimilars. Competition for prescription with Celltrion, which released high-concentration formulations in Korea and with the original drug, is drawing the industry’s attention.According to the Minist
LAS VEGAS, Nev. – By Min Kyeong-joong/Korea Biomedical Review correspondent -- The world’s largest consumer electronics show CES 2023 kicked off with CES Unveiled, a preview of key products open exclusively for over 4,700 media outlets, late Tuesday in Las Vegas, the U.S.Unlike in 2022 when some exh
Celltrion obtained permission from Health Canada to sell Avastin (ingredient: bevacizumab) biosimilar Vegzelma (CT-P16) on Tuesday.Celltrion has obtained permission to sell Vegzelma's full label approved for Avastin in Canada, including indications for metastatic colorectal cancer, non-small cell lu
GE HealthCare said that it has completed the previously announced spinoff from General Electrics (GE) and begun trading as an independent company on the Nasdaq exchange under the ticker symbol "GEHC" from Wednesday.The spinoff of GE Healthcare follows GE's decision to split the company into three se
Daewoong Pharmaceutical said on Thursday that they signed a contract with Oncorus, a U.S. bioventure that develops next-generation RNA-based immunotherapies, for the joint development and commercialization of lipid nanoparticle (LNP) mRNA drugs.Through this contract, the two companies plan to develo
Sanofi Consumer Healthcare (CHC) Korea said Thursday it appointed Cheong Kyung-hui, former general manager (GM) at Pierre Fabre Dermo Cosmetique Korea GM, as its new CEO.Cheong has built her career in the marketing and digital fields at various global companies for the past 26 years, and is evaluate
Korea's first locally-developed new drug Sunpla Injection, a gastric cancer treatment developed by SK Chemicals, has officially lost its approval status, marking the end of the landmark anticancer drug that had spurred new drug development in Korea.According to industry watchers, the Ministry of Foo
Korean pharmaceutical firms and bio companies actively make “open innovation.” Noting that antibody-drug conjugate (ADC) therapies are receiving the spotlight in cancer treatment, related businesses say in unison they would speed up their research and development.Samjin Pharm said Wednesday that it
A research team, consisting of researchers from the Institute for Basic Science (IBS) and Chungnam National University (CNU), identified the cause of the inaccuracy in the drug interaction prediction formula recommended by the U.S. Food and Drug Administration (FDA).According to the team, led by Pro
Korean quarantine authorities are looking for a Chinese national who tested positive for Covid-19 at Incheon Airport Terminal 1 and subsequently fled while moving to the quarantine location.This announcement was made at a regular Covid-19 briefing by the Central Disease Control Headquarters on Tuesd
GC Cell said that it has signed a technology export contract for AB-205, a T-cell lymphoma treatment, with Artiva Biotherapeutics, its U.S. affiliate.According to GC Cell, AB-205 is an allogeneic cord blood-derived NK cell therapy drug equipped with a Chimeric Antigen Receptor (CAR) that targets CD5
Researchers in Korea have found a new way to suppress the growth of the hepatitis C virus.A group of researchers led by Professor Kim Jong-heon at the National Cancer Center (NCC) said Wednesday they have identified a key mechanism for the proliferation of the hepatitis C viruses.If hepatitis C, mai